Findings challenge standard understanding of COVID-19 infection

by Iqbal Pittalwala,University of California - RiversideCredit: Pixabay/CC0 Public DomainSome viruses move between species. For example, SARS-CoV-2, the virus that causes COVID-19, can spill ove

Updated on: June 28,2024

Findings challenge standard understanding of COVID-19 infection

by Iqbal Pittalwala,University of California - RiversideCredit: Pixabay/CC0 Public DomainSome viruses move between species. For example, SARS-CoV-2, the virus that causes COVID-19, can spill ove

Updated on:June 28,2024

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on: December 28,2023

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on:December 28,2023

Novel liquid biopsy methodology enables monitoring of disease evolution in patients with metastatic prostate cancer

byVall d'Hebron Institute of OncologyGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.003Published today inCancer Cell, results of astudy&nb

Updated on: July 09,2024

Novel liquid biopsy methodology enables monitoring of disease evolution in patients with metastatic prostate cancer

byVall d'Hebron Institute of OncologyGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.003Published today inCancer Cell, results of astudy&nb

Updated on:July 09,2024

Biology behind new drug used to treat triple-negative breast cancer uncovered

by Georgetown University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainHow TTP488 (azeliragon), an experimental drug, impairs aggr

Updated on: January 28,2024

Biology behind new drug used to treat triple-negative breast cancer uncovered

by Georgetown University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainHow TTP488 (azeliragon), an experimental drug, impairs aggr

Updated on:January 28,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on: January 30,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on:January 30,2024

Tracing the footprints of a tumor—genomic 'scars' allow cancer profiling

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesHap1 Cells stained for different DNA damages (yellow = antibody against phosphorilated ATM; red = antibody against 53B

Updated on: April 01,2024

Tracing the footprints of a tumor—genomic 'scars' allow cancer profiling

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesHap1 Cells stained for different DNA damages (yellow = antibody against phosphorilated ATM; red = antibody against 53B

Updated on:April 01,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on: January 07,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on:January 07,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on: March 05,2024

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc

Updated on:March 05,2024

Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the

Updated on: June 08,2024

Researchers may have discovered why some tumors grow back aggressively after radiation, chemotherapy

by Laura Castañón,Northeastern UniversityPhoto: Rifat Sipahi, left, and Gunther Zupanc work in a lab in the Mugar Life Sciences Building. Credit: Adam Glanzman/Northeastern UniversityMany of the

Updated on:June 08,2024

Study finds fluorescent guide can help detect tumor left behind after breast cancer surgery

by Mass General BrighamMargin Scoring Schema.Pegulicianine fluorescence-guided surgery (pFGS) readings (positive or negative) from each lumpectomy cavity orientation were compared with hist

Updated on: February 23,2024

Study finds fluorescent guide can help detect tumor left behind after breast cancer surgery

by Mass General BrighamMargin Scoring Schema.Pegulicianine fluorescence-guided surgery (pFGS) readings (positive or negative) from each lumpectomy cavity orientation were compared with hist

Updated on:February 23,2024

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on: July 17,2024

Personalized simulations predict patient outcomes for blood cancer treatment in breakthrough study

byUniversity of SussexComputational modeling of the cell cycle and apoptosis reveal limited impact of archetypal double hit mutations on their respective molecular networks. Credit:Blood C

Updated on:July 17,2024

Study investigates link between oropharyngeal cancer and sexual behavior

byLeipzig UniversityVenn diagrams showing the distribution of self-reported high-risk sexual behavior (HR-SB) among N = 188 propensity-score-matched healthy adults and among N = 94 oropharyngeal

Updated on: January 22,2024

Study investigates link between oropharyngeal cancer and sexual behavior

byLeipzig UniversityVenn diagrams showing the distribution of self-reported high-risk sexual behavior (HR-SB) among N = 188 propensity-score-matched healthy adults and among N = 94 oropharyngeal

Updated on:January 22,2024